KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Equity Ratio (2009 - 2026)

Bristol Myers Squibb (BMY) reported Equity Ratio of 0.23 for Q1 2026, up 7245.55% year-over-year from 0.0 in Q1 2025, and up 13.11% on a QoQ basis from 0.21 in Q4 2025.

Bristol Myers Squibb (BMY) has 18 years of Equity Ratio data on file, last reported at 0.23 in Q1 2026.

  • Quarterly Equity Ratio rose 7245.55% year-over-year to 0.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.23 (up 7245.55% YoY) and the FY2025 annual result came in at 0.21, up 27.41% from the prior year.
  • Equity Ratio advanced to 0.23 in Q1 2026 per BMY's latest filing, from 0.21 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.31 in Q3 2023 and bottomed at 0.44 in Q1 2024.
  • The 5-year median for Equity Ratio is 0.0 (2024), against an average of 0.01.
  • The widest annual swing landed in 2024, when Equity Ratio tumbled 14346.95%; it then jumped 7245.55% in 2026.
  • Tracing BMY's Equity Ratio over 5 years: stood at 0.01 in 2022, then fell by 22.79% to 0.02 in 2023, then surged by 1091.18% to 0.16 in 2024, then advanced by 27.41% to 0.21 in 2025, then rose by 13.11% to 0.23 in 2026.
  • Per Business Quant, the three latest BMY Equity Ratio figures stand at 0.23 (Q1 2026), 0.21 (Q4 2025), and 0.19 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 0.27
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 0.40
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -0.05
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 0.36
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 0.10
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 0.42
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 0.43
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 0.23
10 Gsk 88.34 Bn 83.66 Bn - 0.27

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.23
Dec 31, 2025 0.21
Sep 30, 2025 0.19
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.16
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 -0.44
Dec 31, 2023 -0.02
Sep 30, 2023 0.31
Jun 30, 2023 -0.42
Mar 31, 2023 0.00
Dec 31, 2022 -0.01
Sep 30, 2022 -0.01
Jun 30, 2022 -0.35
Mar 31, 2022 0.00
Dec 31, 2021 0.22
Sep 30, 2021 0.40
Jun 30, 2021 0.00
Mar 31, 2021 0.39
Dec 31, 2020 -0.02
Sep 30, 2020 0.40
Jun 30, 2020 0.38
Mar 31, 2020 0.39
Dec 31, 2019 0.34
Sep 30, 2019 0.31
Jun 30, 2019 0.29
Mar 31, 2019 0.44
Dec 31, 2018 0.00
Sep 30, 2018 0.41
Jun 30, 2018 0.38
Mar 31, 2018 0.39
Dec 31, 2017 0.35
Sep 30, 2017 0.44
Jun 30, 2017 0.44
Mar 31, 2017 0.44
Dec 31, 2016 0.48
Sep 30, 2016 0.47
Jun 30, 2016 0.46
Mar 31, 2016 0.46
Dec 31, 2015 0.45
Sep 30, 2015 0.48
Jun 30, 2015 0.48
Mar 31, 2015 0.47
Dec 31, 2014 0.44
Sep 30, 2014 0.45
Jun 30, 2014 0.46
Mar 31, 2014 0.46
Dec 31, 2013 0.39
Sep 30, 2013 0.40
Jun 30, 2013 0.40
Mar 31, 2013 0.38
Dec 31, 2012 0.38
Sep 30, 2012 0.39
Jun 30, 2012 0.50
Mar 31, 2012 0.50
Dec 31, 2011 0.48
Sep 30, 2011 0.51
Jun 30, 2011 0.51
Mar 31, 2011 0.52
Dec 31, 2010 0.51
Dec 31, 2009 0.48
Sep 30, 2009 0.47
Jun 30, 2009 0.47